bioAffinity Ownership 2024 | Who Owns bioAffinity Now?

Overview RevenueFinancials Chart

Institutional Ownership

2.28%

Insider Ownership

32.91%

Retail Ownership

64.81%

Institutional Holders

6.00

bioAffinity Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CAPTRUST FINANCIAL ADVISORS	0.97%	0.00%	43,642	43,642	100.00%	82,483,000	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	0.59%	0.00%	26,587	26,587	100.00%	50,249,000	Mar 31, 2023
STATE STREET CORP	0.39%	-	17,600	17,600	100.00%	33,264,000	Mar 31, 2023
CREATIVE PLANNING	0.27%	-	12,095	-	-	22,860,000	Mar 31, 2023
UBS GROUP AG	0.05%	-	2,409	-4,172	-63.39%	4,553,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	34	7	25.93%	64,000	Mar 31, 2023
MORGAN STANLEY	-	-	-	-3	-100.00%	-	Mar 31, 2023
FINANCIAL ENGINES ADVISORS L.L.C.	-	-	-	-64,749	-100.00%	-	Mar 31, 2023

bioAffinity's largest institutional shareholder is CAPTRUST FINANCIAL ADVISORS, holding 0.97% of the company's total share outstanding, currently valued at $82.48M. The top 10 institutional shareholders own together 2.28% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CAPTRUST FINANCIAL ADVISORS	0.97%	0.00%	43,642	43,642	100.00%	82,483,000	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	0.59%	0.00%	26,587	26,587	100.00%	50,249,000	Mar 31, 2023
CREATIVE PLANNING	0.27%	-	12,095	-	-	22,860,000	Mar 31, 2023
STATE STREET CORP	0.39%	-	17,600	17,600	100.00%	33,264,000	Mar 31, 2023
UBS GROUP AG	0.05%	-	2,409	-4,172	-63.39%	4,553,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	34	7	25.93%	64,000	Mar 31, 2023
MORGAN STANLEY	-	-	-	-3	-100.00%	-	Mar 31, 2023
FINANCIAL ENGINES ADVISORS L.L.C.	-	-	-	-64,749	-100.00%	-	Mar 31, 2023

The largest bioAffinity shareholder by % of total assets is CAPTRUST FINANCIAL ADVISORS. The company owns 43.64K shares of bioAffinity (BIAF), representing 0.00% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CAPTRUST FINANCIAL ADVISORS	0.97%	0.00%	43,642	43,642	100.00%	82,483,000	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	0.59%	0.00%	26,587	26,587	100.00%	50,249,000	Mar 31, 2023
STATE STREET CORP	0.39%	-	17,600	17,600	100.00%	33,264,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	34	7	25.93%	64,000	Mar 31, 2023
CREATIVE PLANNING	0.27%	-	12,095	-	-	22,860,000	Mar 31, 2023
MORGAN STANLEY	-	-	-	-3	-100.00%	-	Mar 31, 2023
UBS GROUP AG	0.05%	-	2,409	-4,172	-63.39%	4,553,000	Mar 31, 2023
FINANCIAL ENGINES ADVISORS L.L.C.	-	-	-	-64,749	-100.00%	-	Mar 31, 2023

As of Mar 31 2023, bioAffinity's largest institutional buyer is CAPTRUST FINANCIAL ADVISORS. The company purchased 43.64K stocks of BIAF, valued at $82.48M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
FINANCIAL ENGINES ADVISORS L.L.C.	-	-	-	-64,749	-100.00%	-	Mar 31, 2023
UBS GROUP AG	0.05%	-	2,409	-4,172	-63.39%	4,553,000	Mar 31, 2023
MORGAN STANLEY	-	-	-	-3	-100.00%	-	Mar 31, 2023
CREATIVE PLANNING	0.27%	-	12,095	-	-	22,860,000	Mar 31, 2023
WELLS FARGO & COMPANY/MN	0.00%	-	34	7	25.93%	64,000	Mar 31, 2023
STATE STREET CORP	0.39%	-	17,600	17,600	100.00%	33,264,000	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	0.59%	0.00%	26,587	26,587	100.00%	50,249,000	Mar 31, 2023
CAPTRUST FINANCIAL ADVISORS	0.97%	0.00%	43,642	43,642	100.00%	82,483,000	Mar 31, 2023

As of Mar 31 2023, bioAffinity's biggest institutional seller is FINANCIAL ENGINES ADVISORS L.L.C.. The company sold -64.75K shares of BIAF, valued at -.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
CAPTRUST FINANCIAL ADVISORS	0.97%	0.00%	43,642	43,642	100.00%	82,483,000	Mar 31, 2023
TWO SIGMA INVESTMENTS, LP	0.59%	0.00%	26,587	26,587	100.00%	50,249,000	Mar 31, 2023
STATE STREET CORP	0.39%	-	17,600	17,600	100.00%	33,264,000	Mar 31, 2023

bioAffinity's largest new institutional shareholder by number of shares is CAPTRUST FINANCIAL ADVISORS, purchased 43.64K shares, valued at $82.48M, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
FINANCIAL ENGINES ADVISORS L.L.C.	-	-	-	-64,749	-100.00%	-	Mar 31, 2023
MORGAN STANLEY	-	-	-	-3	-100.00%	-	Mar 31, 2023

bioAffinity's largest sold out institutional shareholder by shares sold is FINANCIAL ENGINES ADVISORS L.L.C., sold -64.75K shares, valued at -, as of undefined.

bioAffinity Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
FIDELITY CONCORD STREET TRUST	0.00%	36,513	27,182	291.31%	Feb 29, 2024
VANGUARD INDEX FUNDS	0.00%	70,326	30,326	75.81%	Mar 31, 2024

bioAffinity's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 36.51K shares, compromising 0.00% of its total assets.

bioAffinity Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
31 Mar, 23	6	20.00%
31 Dec, 22	5	25.00%
30 Sep, 22	4	-

As of 31 Mar 23, 6 institutions are holding bioAffinity's shares, representing an increase of 20.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
31 Mar, 23	102,367	22.66%
31 Dec, 22	83,455	26.34%
30 Sep, 22	66,055	-

bioAffinity (BIAF) has 102.37K shares outstanding as of 31 Mar 23, up 22.66% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
31 Mar, 23	2.28%	14.61%
31 Dec, 22	1.99%	-19.60%
30 Sep, 22	2.47%	-

As of 31 Mar 23, bioAffinity is held by 2.28% institutional shareholders, representing a 14.61% growth compared to 31 Dec 22.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
31 Mar, 23	1	-
31 Dec, 22	1	-
30 Sep, 22	-	-

1 institutional shareholders have increased their position in BIAF stock as of 31 Mar 23 compared to 1 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
31 Mar, 23	1	-
31 Dec, 22	1	-
30 Sep, 22	-	-

1 institutional shareholders have reduced their position in BIAF stock as of 31 Mar 23 compared to 1 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
31 Mar, 23	6	20.00%	102,367	22.66%	2.28%	14.61%	1	-	1	-
31 Dec, 22	5	25.00%	83,455	26.34%	1.99%	-19.60%	1	-	1	-
30 Sep, 22	4	-	66,055	-	2.47%	-	-	-	-	-

bioAffinity Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Apr 24, 2024	Zannes Maria	officer	President & CEO	F-InKind	Sell	28,264	$2.65	$74.90K	201,242
Apr 24, 2024	Zannes Maria	officer	President & CEO	M-Exempt	Sell	64,848	$1.16	$75.22K	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 02, 2024	DIAMOND STUART	director	-	A-Award	Buy	33,784	-	-	99,088
Jul 02, 2024	GIRGENTI STEVEN	director, officer	Executive Chairman	A-Award	Buy	33,784	-	-	1,065,248
Jul 02, 2024	Anderson Robert A.	director	-	A-Award	Buy	33,784	-	-	163,936
Jul 02, 2024	Joyce Roby	director	-	A-Award	Buy	33,784	-	-	66,615
Jul 02, 2024	Zannes Maria	director, officer	President & CEO	A-Award	Buy	33,784	-	-	243,322
Jul 02, 2024	Platt Jamie	director	-	A-Award	Buy	33,784	-	-	54,748
Jul 02, 2024	Rubin Gary D	director, 10 percent owner		A-Award	Buy	33,784	-	-	146,597
Jul 02, 2024	KNIGHT PETER S	director	-	A-Award	Buy	33,784	-	-	117,455
Jun 14, 2024	Rubin Gary D	director, 10 percent owner		A-Award	Buy	8,296	-	-	112,813
Jun 14, 2024	DIAMOND STUART	director	-	A-Award	Buy	8,296	-	-	65,304
Jun 14, 2024	GIRGENTI STEVEN	director, officer	Executive Chairman	A-Award	Buy	8,296	-	-	1,031,464
Jun 14, 2024	Zannes Maria	director, officer	President & CEO	A-Award	Buy	8,296	-	-	209,538
Jun 14, 2024	Joyce Roby	director	-	A-Award	Buy	8,296	-	-	32,831
Jun 14, 2024	Platt Jamie	director	-	A-Award	Buy	8,296	-	-	20,964
Jun 14, 2024	KNIGHT PETER S	director	-	A-Award	Buy	8,296	-	-	83,671
Jun 14, 2024	Anderson Robert A.	director	-	A-Award	Buy	8,296	-	-	130,152
Apr 24, 2024	Zannes Maria	officer	President & CEO	M-Exempt	Buy	64,848	$1.16	$75.22K	229,506
Apr 24, 2024	Zannes Maria	officer	President & CEO	F-InKind	Sell	28,264	$2.65	$74.90K	201,242
Apr 24, 2024	Zannes Maria	officer	President & CEO	M-Exempt	Sell	64,848	$1.16	$75.22K	-
Apr 24, 2024	Zannes Timothy P	officer	Secretary, EVP, Gen. Counsel	M-Exempt	Buy	64,848	$1.16	$75.22K	75,155

The last insider sell of bioAffinity's stock was made by Zannes Maria on Apr 24 2024, selling 28,264 shares at $2.65 per share (valued at $74.90K).

bioAffinity Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	8	-	-
Q2 2024	11	6	183.33%
Q1 2024	16	1	1600.00%
Q4 2023	8	-	-
Q3 2023	9	1	900.00%
Q2 2023	10	-	-
Q1 2023	8	-	-
Q4 2022	4	-	-
Q3 2022	65	36	180.56%
Q4 2021	-	-	-
Q3 2021	-	1	-
Q3 2017	-	2	-

8 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by bioAffinity's insiders, as of Q3 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	-	-	-
Q2 2024	-	-	-
Q1 2024	-	-	-
Q4 2023	-	-	-
Q3 2023	-	-	-
Q2 2023	-	-	-
Q1 2023	-	-	-
Q4 2022	-	-	-
Q3 2022	21	-	-
Q4 2021	-	-	-
Q3 2021	-	-	-
Q3 2017	-	-	-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of bioAffinity's stocks.

bioAffinity Peer Ownership

Ticker	Company
GTH	Genetron Holdings Limited
HTGM	HTG Molecular Diagnostics, Inc.
BIOC	Biocept, Inc.
GENE	Genetic Technologies Limited
SQL	SeqLL Inc.
PMD	Psychemedics Corporation
TTOO	T2 Biosystems, Inc.
INBS	Intelligent Bio Solutions Inc.
PRPO	Precipio, Inc.

BIAF Ownership FAQ

Who Owns bioAffinity?

bioAffinity is owned by institutional shareholders (2.28%), insiders (32.91%), and public (64.81%). The largest institutional shareholder of bioAffinity is CAPTRUST FINANCIAL ADVISORS (0.97% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).

Who are the major institutional shareholders of bioAffinity?

bioAffinity's major institutional shareholders are CAPTRUST FINANCIAL ADVISORS, TWO SIGMA INVESTMENTS, LP, STATE STREET CORP, CREATIVE PLANNING, and UBS GROUP AG. The top five shareholders own together 2.27% of the company's share outstanding.

How many bioAffinity shareholders are there?

As of Mar 2023, there are 6 institutional shareholders of bioAffinity.

What percentage of bioAffinity is owned by CAPTRUST FINANCIAL ADVISORS?

CAPTRUST FINANCIAL ADVISORS owns 43.64K shares of bioAffinity, representing 0.97% of the company's total shares outstanding, valued at $82.48M (as of Mar 2023).

What percentage of bioAffinity is owned by TWO SIGMA INVESTMENTS, LP?

As of Mar 2023, TWO SIGMA INVESTMENTS, LP holds 26.59K shares of bioAffinity (BIAF), compromising 0.59% of the company, valued at $50.25M.

What percentage of bioAffinity is owned by STATE STREET CORP?

STATE STREET CORP is the third largest holder of bioAffinity. The company owns 17.6K of the company's shares outstanding (worth $33.26M).